| # | Country | Total Patents | |
|---|---|---|---|
| #1 | China | 13 | |
| #2 | WIPO (World Intellectual Property Organization) | 3 | |
| #3 | Australia | 2 | |
| #4 | Canada | 1 | |
| #5 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Machines | |
| #4 | Computer technology | |
| #5 | Measurement | |
| #6 | Foods and drinks |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations | |
| #4 | Microorganisms | |
| #5 | Unspecified technologies | |
| #6 | Measuring microorganism processes | |
| #7 | Image data processing | |
| #8 | Fermentation | |
| #9 | Enzymes | |
| #10 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Boon-Falleur Thierry | 4 |
| #2 | Alitalo Kari | 3 |
| #3 | Eriksson Ulf | 3 |
| #4 | Olofsson Birgitta | 2 |
| #5 | Gnjatic Sacha | 2 |
| #6 | Old Lloyd J | 2 |
| #7 | Alitalo K | 2 |
| #8 | Atanackovic Djordje | 2 |
| #9 | Jeltsch Markku | 2 |
| #10 | Olofsson B | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO2009035629A1 | Method for modifying cellular immune response by modulating activin activity | |
| CN101939332A | Truncated variant of the mammalian target for rapamycin (mTOR) protein | |
| US2008139464A1 | Isolated Ny-Eso-1 Peptides Which Bind To Hla Class II Molecules And Uses Thereof | |
| CN1275050A | Stimulation, modulation and/or inhibition of endothelial proteolytic activity and/or angiogenic activity |